OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
YY1-induced upregulation of LncRNA-ARAP1-AS2 and ARAP1 promotes diabetic kidney fibrosis via aberrant glycolysis associated with EGFR/PKM2/HIF-1α pathway
Xin Li, Tian‐Kui Ma, Min Wang, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 9
Xin Li, Tian‐Kui Ma, Min Wang, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 9
Showing 9 citing articles:
HOXD10 attenuates renal fibrosis by inhibiting NOX4-induced ferroptosis
Xin Li, Tian‐Kui Ma, Pu Wang, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 6
Open Access | Times Cited: 7
Xin Li, Tian‐Kui Ma, Pu Wang, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 6
Open Access | Times Cited: 7
Apabetalone, a BET protein inhibitor, inhibits kidney damage in diabetes by preventing pyroptosis via modulating the P300/H3K27ac/PLK1 axis
Min Wang, Zhaohui Huang, Xin Li, et al.
Pharmacological Research (2024) Vol. 207, pp. 107306-107306
Open Access | Times Cited: 5
Min Wang, Zhaohui Huang, Xin Li, et al.
Pharmacological Research (2024) Vol. 207, pp. 107306-107306
Open Access | Times Cited: 5
Modification of RNF183 via m6A Methylation Mediates Podocyte Dysfunction in Diabetic Nephropathy by Regulating PKM2 Ubiquitination and Degradation
Dongwei Guo, Yu Pang, Wenjie Wang, et al.
Cells (2025) Vol. 14, Iss. 5, pp. 365-365
Open Access
Dongwei Guo, Yu Pang, Wenjie Wang, et al.
Cells (2025) Vol. 14, Iss. 5, pp. 365-365
Open Access
RNA-Based Therapies in Kidney Diseases
Liang Hu, Ting Jin, Ning Zhang, et al.
Journal of Inflammation Research (2025) Vol. Volume 18, pp. 3143-3160
Open Access
Liang Hu, Ting Jin, Ning Zhang, et al.
Journal of Inflammation Research (2025) Vol. Volume 18, pp. 3143-3160
Open Access
YY1/HIF-1α/mROS positive-feedback loop exacerbates glomerular mesangial cell proliferation in mouse early diabetic kidney disease
Tingting Yang, Yingkuan Shao, Cheng Qian, et al.
Acta Pharmacologica Sinica (2025)
Closed Access
Tingting Yang, Yingkuan Shao, Cheng Qian, et al.
Acta Pharmacologica Sinica (2025)
Closed Access
The multiple functions and mechanisms of long non-coding RNAs in regulating breast cancer progression
Yongsheng Zhang, Yanjiao Xu, Yanping Zhang, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Yongsheng Zhang, Yanjiao Xu, Yanping Zhang, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Mechanisms of hepatic and renal injury in lipid metabolism disorders in metabolic syndrome
Jin Rong, Zixuan Zhang, Xiaoyu Peng, et al.
International Journal of Biological Sciences (2024) Vol. 20, Iss. 12, pp. 4783-4798
Open Access | Times Cited: 3
Jin Rong, Zixuan Zhang, Xiaoyu Peng, et al.
International Journal of Biological Sciences (2024) Vol. 20, Iss. 12, pp. 4783-4798
Open Access | Times Cited: 3
Targeting pyruvate kinase M2 for the treatment of kidney disease
Dan‐Qian Chen, Jin Han, Hongxing Liu, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 2
Dan‐Qian Chen, Jin Han, Hongxing Liu, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 2
The Bromodomain and extra-terminal Protein Inhibitor Apabetalone ameliorates kidney injury in diabetes by regulating cholesterol accumulation and modulating the gut microbiota
Min Wang, Zhaohui Huang, Yonghong Zhu, et al.
Kidney International Reports (2024)
Open Access | Times Cited: 1
Min Wang, Zhaohui Huang, Yonghong Zhu, et al.
Kidney International Reports (2024)
Open Access | Times Cited: 1
